Helen

I, Helen Tope, nominated by, and residing in, Australia, co-chair of the Medical and Chemicals Technical Options Committee and co-chair of the Decision XXXI/3 Task Force on Unexplained Emissions of CFC-11, and member of the Technology and Economic Assessment Panel (TEAP), declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Principal Consultant and also Director of Planet Futures, and former Principal Consultant of Energy International Australia P.L. My responsibilities include acting as an independent consultant providing strategic, policy and technical advice and facilitation services to government, industry and other non-governmental organisations on climate change, ozone-depleting substances, and other environmental issues.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents, include the following:
   1. Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g. task forces).
   2. Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work, including the outcome of assessments of essential use nominations, destruction technologies or process agent applications.
   3. Employment, consultancy, directorship or other positions: My business has an interest in the topics of the Montreal Protocol because my potential clients are also interested in these topics, and I consult for organisations that support the Montreal Protocol in phasing out controlled substances. My spouse, Mr. Michael Atkinson, is also my business partner whose business has an interest in the topics of the Montreal Protocol. During 2010, Dr. Stephen O. Andersen, Mr. Atkinson and I were unpaid advisors to a UNEP project on investment metrics for identifying technology that minimizes climate and other impacts when replacing ozone-depleting and high-GWP substances. In 2012, the Australian Government’s then Department of Sustainability, Environment, Water, Population and Communities engaged then Energy International Australia to conduct a periodic review of Australia’s halon essential uses requirements in the civilian sector. In 2019-2020, the Australian Government’s Department of Agriculture, Water and the Environment engaged Planet Futures to conduct a review of Australia’s future non-defence halon requirements. During 2021, I am contracted by UNEP to write a number of articles of a technical nature for its website. During 2021, I am participating as an unpaid contributor to an Environmental Impact of Inhaled Medicines Writing Group of the Thoracic Society of Australia and New Zealand.
   4. Government advice and other policy development: See above under c.
   5. Paid research activities, fellowships or grants: None.
   6. Other interests: None.
5. The Ozone Secretariat has offered funding support towards administrative costs and travel, if any, associated with my participation as co-chair of the Medical and Chemicals Technical Options Committee, co-chair of the Decision XXXI/3 Task Force on Unexplained Emissions of CFC-11, and member of the Technology and Economic Assessment Panel in 2021. As a self-employed consultant, I conduct work related to the Medical and Chemicals Technical Options Committee and the Technology and Economic Assessment Panel and its subsidiary bodies also on a voluntary (unpaid) basis.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have declined to disclose information falling within paragraph 10 of those Guidelines and I undertake to ensure that I am completely excluded from discussion and decisions on topics related to the information that I have declined to disclose. 
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: Helen Tope

Date: 18th March 2021